Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
TWST Stock Chart & Stats
$26.00
-$0.78(-1.71%)
At close: 4:00 PM EST
$26.00
-$0.78(-1.71%)
Day’s Range― - ―
52-Week Range$23.30 - $55.33
Previous CloseN/A
Volume152.02K
Average Volume (3M)1.62M
Market Cap
$2.02B
Enterprise Value$1.54B
Total Cash (Recent Filing)$232.43M
Total Debt (Recent Filing)$75.57M
Price to Earnings (P/E)―
Beta2.11
Next Earnings
Jan 30, 2026EPS Estimate
-0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding61,148,026
10 Day Avg. Volume1,263,242
30 Day Avg. Volume1,623,284
Financial Highlights & Ratios
PEG Ratio0.34
Price to Book (P/B)3.56
Price to Sales (P/S)4.47
P/FCF Ratio-22.25
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue4.10
Enterprise Value/Gross Profit8.08
Enterprise Value/Ebitda-29.57
Forecast
1Y Price Target
$38.00Price Target Upside46.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Biopharma StrengthManagement noted recent biopharma strength tied to the expansion of AI-driven drug discovery tools and the growing demand for more custom, unique sequences which plays to Twist's strength.
DNA Synthesis And Protein Solutions GuideThere is a strong 'DNA Synthesis and Protein Solutions' guide which suggests that high-teens-plus top-line growth is still intact as the company continues to penetrate large and growing end-markets.
Proprietary Technology AdvantagesTwist Bioscience's proprietary silicon chip technology provides advantages in cost, speed, and scale.
Bears Say
Growth Deceleration ConcernsShares closed down 10% with the debate centering on whether the guide is reflective of the bear case, indicating a deceleration in growth potential.
Guidance Below ExpectationsThe company's 2026 guidance for revenue and gross margin is below what analysts had expected.
Sequential Decline In NGS RevenuesSequential decline in NGS revenues was noted for the first time in ten quarters, which may raise concerns about sustained growth in this segment.
Twist Bioscience News
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $23.30 and its highest was $55.33 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Twist Bioscience Corp’s market cap is $2.02B.
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is Jan 30, 2026 which is in 32 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Nov 14, 2025. The company reported -$0.45 earnings per share for the quarter, missing the consensus estimate of -$0.415 by -$0.035.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -0.43.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 61,148,026 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.45 in its last earnings report, missing expectations of -$0.415. Following the earnings report the stock price went down -10.134%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Currently, no hedge funds are holding shares in TWST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Twist Bioscience Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$38.00 (46.15% Upside)
$38.00 (46.15% Upside)
Blogger Sentiment
Neutral
TWST Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 326.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $174.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.6%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.34%
12-Months-Change
Fundamentals
Return on Equity
-16.43%
Trailing 12-Months
Asset Growth
4.48%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience is a biotechnology company that specializes in synthetic DNA production and gene synthesis. Founded in 2013 and headquartered in San Francisco, California, the company operates primarily in the life sciences sector and serves various industries including pharmaceuticals, agriculture, and industrial biotechnology. Twist Bioscience's core products include synthetic genes, gene fragments, and other DNA-based products, which are utilized in research, development, and manufacturing processes.
TWST Company Deck
TWST Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Twist Bioscience reported strong financial performance with record revenue and significant margin improvement, driven by growth in SynBio, Biopharma, and NGS segments. However, the transition of a major customer and moderate growth guidance for fiscal 2026 presents challenges. The company is optimistic about future growth driven by AI-enabled discovery and new product introductions.View all TWST earnings summariesTWST Stock 12 Month Forecast
Average Price Target
$38.00
▲(46.15% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---